Health Titan Sheds 5% On A Rare Guidance Miss - Investor's Business Daily

Abbott stock dropped early Thursday after the health giant lowered its sales outlook for 2025 following a mixed second-quarter report. For the year, Abbott Laboratories (ABT) now expects sales to gr…